| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.3M | -9.7% |
| SG&A Expense | $4.4M | -1.9% |
| Operating Income | -$10.8M | +5.6% |
| Income Tax | $0 | — |
| Net Income | -$10.8M | +5.7% |
| EPS (Basic) | -$5.20 | +48.5% |
| EPS (Diluted) | -$5.20 | +48.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Current Assets | $9.3M | -25.1% |
| Total Assets | $9.4M | -26.9% |
| Current Liabilities | $1.6M | -15.7% |
| Total Liabilities | $1.6M | -17.2% |
| Stockholders' Equity | $7.7M | -28.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | +11.4% |
| Capital Expenditures | $5K | -95.9% |
| Investing Cash Flow | -$5K | +95.9% |
| Financing Cash Flow | $7.4M | — |
| Free Cash Flow | -$10.8M | +12.2% |